Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome

European Neurology

Volumn 45, Issue 4, 2001, Pages 287-288

  Dressler, D ^a   Wittstock, M ^a   Benecke, R ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; HALLERVORDEN SPATZ DISEASE; HUMAN; JAW DISEASE; JAW OPENING DYSTONIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; DYSTONIC DISORDERS; HALLERVORDEN-SPATZ SYNDROME; HUMANS; INJECTIONS, INTRAMUSCULAR; JAW DISEASES; MALE; NEUROMUSCULAR AGENTS;

EID: 0035016293     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052146     Document Type: Article

References (9)

1. Eigenartige erkrankung im extrapyramidalen system mit besonderer beteiligung des globus pallidus und der substantia nigra
2. Hallervorden-Spatz syndrome: Clinical and magnetic resonance imaging correlations
3. Hallervorden-Spatz syndrome
4. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism
5. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia
6. Stereotactic pallidotomy in a child with Hallervorden-Spatz disease. Case report
7. Botulinum toxin therapie in der rehabilitationsneurologie
8. Oromandibular dystonia: Treatment of 96 patients with botulinum toxin type A